Evidence map›Paper›PMID 32429362›Full record

ArticlePharmacy (Basel, Switzerland)2020

Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice.

Olga Lourenço, Sinthia Bosnic-Anticevich, Elísio Costa, João A Fonseca, Enrica Menditto, Biljana Cvetkovski, Vicky Kritikos, Rachel Tan, Anna Bedbrook, Sophie Scheire and 12 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Pharmacy (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06027736 (The Effectiveness of Pharmacist-led Educational Model in Patients With Allergic Rhinitis in a Malaysian Tertiary Hospital), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06027736 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Effectiveness of Pharmacist-led Educational Model in Patients With Allergic Rhinitis in a Malaysian Tertiary Hospital: A Randomised Control Trial Protocol (AR-PRISE RCT)

TypeinterventionalSponsorDr. Chee Ping ChongRan2023 to 2024Enrolled154ConditionsAllergic Rhinitis, Pharmaceutical Care, Pharmaceutical ServicesArmspharmacist-led education
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Reshaping the Management of Allergic Rhinitis in Primary Care: Lessons from the COVID-19 Pandemic.International journal of environmental research and public health · 2022
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. How Do Pollen Allergens Sensitize?Frontiers in molecular biosciences · 2022
    Review
  15. Allergic rhinitis self-care advice in community pharmacies: A simulated patient study.Exploratory research in clinical and social pharmacy · 2021
    Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 15 institutions in 13 countries.

Olga LourençoFaculty of Health Sciences and CICS-UBI, Health Sciences Research Centre, University of Beira Interior, 6200-506 Covilhã, Portugal.ORCID 0000-0002-8401-5976
Sinthia Bosnic-AnticevichWoolcock Institute of Medical Research, University of Sidney and Sydney Local Health District, Sydney 2037, Australia.
Elísio CostaUCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (AgeUPNetWork), University of Porto, 4150 Porto, Portugal.
João A FonsecaCINTESIS, Center for Research in Health Technologies and Information Systems, Faculdade de Medicina da Universidade do Porto e MEDIDA, Lds., 4200-450 Porto, Portugal.ORCID 0000-0002-0887-8796
Enrica MendittoCIRFF, Center of Pharmacoeconomics, University of Naples Federico II, 80138 Naples, Italy.
Biljana CvetkovskiWoolcock Institute of Medical Research, University of Sidney and Sydney Local Health District, Sydney 2037, Australia.
Vicky KritikosWoolcock Institute of Medical Research, University of Sidney and Sydney Local Health District, Sydney 2037, Australia.
Rachel TanWoolcock Institute of Medical Research, University of Sidney and Sydney Local Health District, Sydney 2037, Australia.
Anna BedbrookMACVIA-France, 34295 Montpellier, France.
Sophie ScheirePharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.ORCID 0000-0001-9623-4458
Claus BachertUpper Airways Research Laboratory, ENT Dept, Ghent University Hospital, 9000 Ghent, Belgium.
Sławomir BiałekDepartment of Biochemistry and Clinical Chemistry, Faculty of Pharmacy with the Division of Laboratory Medicine, Warsaw Medical University, 02-091 Warsaw, Poland.
Vitalis BriedisDepartment of Clinical Pharmacy of Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania.
Koen BousseryPharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.
G Walter CanonicaPersonalized Medicine Clinic Asthma & Allergy, Humanitas University, Humanitas Research Hospital, 20089 Rozzano MI, Italy.
Tari HaahtelaSkin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, 00100 Helsinki, Finland.
Piotr KunaDivision of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Łódź, 90-419 Łódź, Poland.
Ettore NovellinoDepartment of Pharmacy of the University of Naples Federico II, 80138 Naples, Italy.
Bolesław SamolińskiDepartment of Prevention of Environmental Hazards and Allergology, Warsaw Medical University, 02-091 Warsaw, Poland.
Holger J SchünemannDepartment of Health Research Methods, Evidence, and Impact, Division of Immunology and Allergy, Department of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
Dana WallaceNova Southeastern University, Fort Lauderdale, FL 33314, USA.
Jean BousquetMACVIA-France, 34295 Montpellier, France.
The University of Sydney · AUGhent University · BEMedical University of Warsaw · PLUniversidade do Porto · PTUniversity of Naples Federico II · ITGefluc Languedoc Roussillon · FRHumanitas University · ITHumboldt-Universität zu Berlin · DEImpact · CALithuanian University of Health Sciences · LTMedical University of Lodz · PLNova Southeastern University · USSun Yat-sen University · CNUniversity of Beira Interior · PTUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The paradigm of how we manage allergic rhinitis is shifting with a growing understanding that it is a complex process, requiring a coordinated effort from healthcare providers and patients. Pharmacists are key members of these integrated care pathways resolving medication-related problems, optimizing regimens, improving adherence and recommending therapies while establishing liaisons between patients and physicians. Community pharmacists are the most accessible healthcare professionals to the public and allergic rhinitis is one of the most common diseases managed by pharmacists. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines developed over the past 20 years have improved the care of allergic rhinitis patients through an evidence-based, integrated care approach. In this paper, we propose an integrated approach to allergic rhinitis management in community pharmacy following the 2019 ARIA in the pharmacy guidelines.

Indexed as

allergic rhinitiscommunity pharmacypharmacist

Identifiers

PMID32429362
PMCPMC7355936
OpenAlexW3025027308

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.